1. Home
  2. LUNG vs GHI Comparison

LUNG vs GHI Comparison

Compare LUNG & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • GHI
  • Stock Information
  • Founded
  • LUNG 1995
  • GHI 1998
  • Country
  • LUNG United States
  • GHI United States
  • Employees
  • LUNG N/A
  • GHI N/A
  • Industry
  • LUNG Industrial Specialties
  • GHI Finance: Consumer Services
  • Sector
  • LUNG Health Care
  • GHI Finance
  • Exchange
  • LUNG Nasdaq
  • GHI Nasdaq
  • Market Cap
  • LUNG 299.3M
  • GHI 285.3M
  • IPO Year
  • LUNG 2020
  • GHI N/A
  • Fundamental
  • Price
  • LUNG $6.74
  • GHI $12.87
  • Analyst Decision
  • LUNG Strong Buy
  • GHI Strong Buy
  • Analyst Count
  • LUNG 7
  • GHI 3
  • Target Price
  • LUNG $12.64
  • GHI $16.50
  • AVG Volume (30 Days)
  • LUNG 258.8K
  • GHI 43.8K
  • Earning Date
  • LUNG 04-30-2025
  • GHI 05-07-2025
  • Dividend Yield
  • LUNG N/A
  • GHI 11.64%
  • EPS Growth
  • LUNG N/A
  • GHI N/A
  • EPS
  • LUNG N/A
  • GHI 0.76
  • Revenue
  • LUNG $83,789,000.00
  • GHI $32,275,700.00
  • Revenue This Year
  • LUNG $17.96
  • GHI $226.38
  • Revenue Next Year
  • LUNG $18.35
  • GHI N/A
  • P/E Ratio
  • LUNG N/A
  • GHI $16.73
  • Revenue Growth
  • LUNG 22.01
  • GHI N/A
  • 52 Week Low
  • LUNG $5.46
  • GHI $10.12
  • 52 Week High
  • LUNG $10.01
  • GHI $16.41
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 39.61
  • GHI 54.07
  • Support Level
  • LUNG $7.65
  • GHI $12.78
  • Resistance Level
  • LUNG $7.97
  • GHI $13.10
  • Average True Range (ATR)
  • LUNG 0.47
  • GHI 0.35
  • MACD
  • LUNG -0.14
  • GHI -0.02
  • Stochastic Oscillator
  • LUNG 11.25
  • GHI 50.36

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.

Share on Social Networks: